Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:45 AM
Ignite Modification Date:
2025-12-24 @ 11:45 AM
NCT ID:
NCT07074561
Eligibility Criteria:
Inclusion Criteria:
* Participants must meet all of the following criteria to be eligible for this study:
1. Met the diagnostic criteria for trigeminal neuralgia (TN) as defined in the International Classification of Headache Disorders, 3rd edition (ICHD-3) published by the International Headache Society (IHS) in 2018.
2. Between 18 and 75 years old (inclusive), regardless of gender;
3. Currently prescribed carbamazepine (400-800 mg/day) or oxcarbazepine (800-1600 mg/day);
4. Conscious, alert, and capable of perceiving/differentiating pain, with basic communication abilities;
5. Signed informed consent form and voluntary participation in the study.
Exclusion Criteria:
* Patients meeting any of the following criteria were excluded:
1. Patients with epilepsy, head injury, or other relevant neurological disorders;
2. Patients with severe cardiac, hepatic, or renal impairment;
3. Patients with cognitive dysfunction, aphasia, psychiatric disorders, or those unable to cooperate with treatment;
4. Patients with poorly controlled hypertension or hyperglycemia;
5. Patients with a recent diagnosis of severe anxiety or depression;
6. Pregnant or breastfeeding patients;
7. Patients with pacemakers or other contraindications to electroacupuncture;
8. Patients concurrently enrolled in other clinical studies.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT07074561
Study Brief:
Protocol Section:
NCT07074561